Found: 19
Select item for more details and to access through your institution.
Corticocortical connections predict patches of stimulus-evoked metabolic activity in monkey somatosensory cortex.
- Published in:
- Journal of Comparative Neurology, 1990, v. 298, n. 1, p. 23, doi. 10.1002/cne.902980103
- By:
- Publication type:
- Article
Cholinergic manipulation alters stimulus-evoked metabolic activity in cat somatosensory cortex.
- Published in:
- Journal of Comparative Neurology, 1990, v. 297, n. 1, p. 106, doi. 10.1002/cne.902970108
- By:
- Publication type:
- Article
Cellular and Organismal Toxicity of the Anti-Cancer Small Molecule, Tolfenamic Acid: a Pre-Clinical Evaluation.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2013, v. 32, n. 3, p. 675, doi. 10.1159/000354471
- By:
- Publication type:
- Article
A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma.
- Published in:
- Cancer Reports, 2022, v. 5, n. 11, p. 1, doi. 10.1002/cnr2.1616
- By:
- Publication type:
- Article
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trial.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01297-5
- By:
- Publication type:
- Article
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 5, p. 1, doi. 10.1371/journal.pone.0127246
- By:
- Publication type:
- Article
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 6, p. 871, doi. 10.1002/cam4.436
- By:
- Publication type:
- Article
THER-21. TARGETING LIN28 WITH DFMO IN PATIENTS WITH ETMR SUGGESTS CLINICAL BENEFIT.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii118, doi. 10.1093/neuonc/noz036.226
- By:
- Publication type:
- Article
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 5, p. 1026, doi. 10.1002/ijc.34569
- By:
- Publication type:
- Article
Correction to: Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers.
- Published in:
- Journal of Clinical Immunology, 2024, v. 44, n. 3, p. 1, doi. 10.1007/s10875-024-01677-x
- By:
- Publication type:
- Article
Clinical and Treatment History of Patients with Partial DiGeorge Syndrome and Autoimmune Cytopenia at Multiple Centers.
- Published in:
- Journal of Clinical Immunology, 2024, v. 44, n. 2, p. 1, doi. 10.1007/s10875-023-01607-3
- By:
- Publication type:
- Article
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 11, p. 3152, doi. 10.1002/ijc.33044
- By:
- Publication type:
- Article
A Phase 1 Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients with Refractory or Recurrent Neuroblastoma or Medulloblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: A novel therapeutic agent for neuroblastoma.
- Published in:
- Molecular Carcinogenesis, 2013, v. 52, n. 5, p. 377, doi. 10.1002/mc.21866
- By:
- Publication type:
- Article
Anti-leukemic response of a NSAID, tolfenamic acid.
- Published in:
- Targeted Oncology, 2014, v. 9, n. 2, p. 135, doi. 10.1007/s11523-013-0274-9
- By:
- Publication type:
- Article
Prognostic significance of early lymphocyte recovery in pediatric osteosarcoma.
- Published in:
- Pediatric Blood & Cancer, 2010, v. 55, n. 6, p. 1096, doi. 10.1002/pbc.22673
- By:
- Publication type:
- Article
Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
- Published in:
- Apoptosis, 2019, v. 24, n. 1/2, p. 21, doi. 10.1007/s10495-018-1508-1
- By:
- Publication type:
- Article
Maintenance DFMO Increases Survival in High Risk Neuroblastoma.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-32659-w
- By:
- Publication type:
- Article
Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
- Published in:
- International Journal of Developmental Neuroscience, 2015, v. 46, p. 92, doi. 10.1016/j.ijdevneu.2015.07.012
- By:
- Publication type:
- Article